Varaico: Literature-Extracted Genetic Variants

Gene:NAXE
Variant:p.K245Q
Back to variants list

NAXE

NM_144772.3:p.K245Q

Associated Papers

Deficiency of the NAD(P)HX metabolic repair system: a treatable mitochondrial disease.

Xu C et al.

Orphanet Journal of Rare Diseases, 2026

Progressive encephalopathy associated with novel compound heterozygous NAXE mutations in a Chinese patient: case report and literature review.

Zhu Y et al.

Frontiers in Pediatrics, 2026

Biallelic GGGCC repeat expansion leading to NAXE-related mitochondrial encephalopathy.

Ozaki K et al.

Npj Genomic Medicine, 2024

Transient response to high-dose niacin therapy in a patient with NAXE deficiency.

Al-Amrani F et al.

Jimd Reports, 2024

AIBP: A New Safeguard against Glaucomatous Neuroinflammation.

Choi S et al.

Cells, 2024

Long-term follow-up of an attenuated presentation of NAXE-related disease, a potentially actionable neurometabolic disease: a case report.

Almudhry M et al.

Frontiers in Neurology, 2024

De novo mutation of NAXE (APOAIBP)-related early-onset progressive encephalopathy with brain edema and/or leukoencephalopathy-1: A case report.

Ding L et al.

World Journal of Clinical Cases, 2023

Clinical and biochemical distinctions for a metabolite repair disorder caused by NAXD or NAXE deficiency.

Van Bergen NJ et al.

Journal of Inherited Metabolic Disease, 2022

35866541 (PubMed )
Supplement: JIMD-45-1028-s001.xlsx › Sheet2

NAXE deficiency: A neurometabolic disorder of NAD(P)HX repair amenable for metabolic correction.

Manor J et al.

Molecular Genetics and Metabolism, 2022

NAXE gene mutation-related progressive encephalopathy: A case report and literature review.

Chiu LW et al.

Medicine, 2021

Deciphering genes associated with diffuse large B-cell lymphoma with lymphomatous effusions: A mutational accumulation scoring approach.

Abdollahi S et al.

Biomarker Research, 2021

34635181 (PubMed )
Supplement: 40364_2021_330_MOESM2_ESM.xlsx › ___1

Genetic heterogeneity in Leigh syndrome: Highlighting treatable and novel genetic causes.

Lee JS et al.

Clinical Genetics, 2020

Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment.

Trinh J et al.

Journal of Neurology, 2020

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."